Sierra Oncology Inc (SRRA) - Pharmaceuticals & Hea
Publicado el en “Mundo”, Idioma — English. 5 páginas.
It is also developing SRA141, a small molecule inhibitor of the cell division cycle 7 kinase (Cdc7). The company has presence in the US and Canada. Sierra Oncology is headquartered in Vancouver, British Columbia, Canada. Más
